Clinical Trials in Atlanta

Showing 17001-17020 of 19,805 trials

Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia

NCT00821600

The purpose of this study is to explore the pharmacokinetics, safety and tolerability of a 4-week long-acting injectable (LAI) formulation of risperidone after single intramuscular (i.m.) injection of 75 mg risperidone LAI in the gluteal muscle.

Psychotic DisordersSchizophrenia

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.24 participantsStarted Dec 2008

Cerritos, California, United States • Santa Ana, California, United States • Atlanta, Georgia, United States

COMPLETEDPhase 3< 1 mile

National Lung Screening Trial (NLST) Screening

NCT00047385

RATIONALE: Effective screening tests should help doctors detect lung cancer early and plan curative treatment. It is not yet known whether low-dose helical computed tomography (LDCT) screening is more effective than chest radiography (CXR) screening in reducing death from lung cancer. PURPOSE: Randomized clinical trial to compare the effectiveness of LDCT scan with that of CXR in screening individuals who are at high risk for developing lung cancer.

Lung Cancer

National Cancer Institute (NCI)53,454 participantsStarted Aug 2002

Birmingham, Alabama, United States • La Jolla, California, United States • Los Angeles, California, United States +30 more locations

Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia

National Lung Screening Trial (NLST) Screening

Find Trials by Condition in Atlanta

Fixed 100 mg Every Evening of Flibanserin vs Placebo in Premenopausal Women With Hypoactive Sexual Desire Disorder

Sofosbuvir + Ribavirin for 12 Weeks in Subjects With Chronic Genotype 2 or 3 Hepatitis C Infection Who Are Interferon Intolerant, Interferon Ineligible or Unwilling to Take Interferon

Safety and Efficacy in Type 2 Diabetic Patients With Severe Chronic Renal Impairment, 5 mg BI 1356 (Linagliptin) vs. Placebo, Insulin Background Inclusive

Secondary Prevention of Venous Thrombo Embolism (VTE).

Effectiveness and Safety of Ramipril Alone Compared With Telmisartan Alone and in Combination With Ramipril in Patients at High Risk for Cardiovascular Events. Patients Intolerant to Ramipril Were Entered in TRANSCEND, Telmisartan Compared to Placebo.

Effects of Docosahexaenoic Acid (DHA) on Cognitive Function in Children 4 Years of Age

1st or 2nd Line MBC (Metastatic Breast Cancer) With Previous Avastin (Bevacizumab) Therapy

A Study for Participants With Recurrent or Metastatic Squamous Cell Head and Neck Cancer

Safety and Effectiveness Study of RWJ-445380 Cathepsin-S Inhibitor in Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy

Study of Epratuzumab in Systemic Lupus Erythematosus

Trial Comparing Tiotropium Inhalation Capsules vs Placebo in Chronic Obstructive Pulmonary Disease (COPD).

Tiotropium / Respimat One-Year Study

Pharmacokinetics of Flibanserin in Postmenopausal Women With Hypoactive Sexual Desire Disorder (HSDD)

Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

Long-term, Open-label Follow-up Treatment of Patients With A-fib Who Have Been Previously Treated With BIBR 1048

Collection of Blood Samples From HIV Infected People

Vaccine Therapy in Treating Patients With Stage II Melanoma That Can Be Removed by Surgery

Action in Diabetes and Vascular Disease Preterax and Diamicron MR Controlled Evaluation Post Trial Observational Study